Gandhi Medicos Logo
Back to health articles
Small Cell vs Non-Small Cell Lung Cancer

Small Cell vs Non-Small Cell Lung Cancer

Erlonat Tablet 100 mg (Erlotinib) for Lung Cancer Lung cancer is divided into two types: Small Cell and Non-Small Cell. Small cell lung cancer is a disorder in which malignant (cancer) cells develop in lung tissues. Small cell lung cancer is divided into two categories. These two categories of cells contain a wide range of

Gandhi Medicos January 12, 2022 3 minutes

Erlonat Tablet 100 mg (Erlotinib) for Lung Cancer

Lung cancer is divided into two types: Small Cell and Non-Small Cell.

Small cell lung cancer is a disorder in which malignant (cancer) cells develop in lung tissues. Small cell lung cancer is divided into two categories. These two categories of cells contain a wide range of cell types. Each type of cancer cell grows and spreads uniquely. The many varieties of small cell lung cancer are called after the different types of cells seen in the tumor and how they appear under a microscope.

  • Small cell carcinoma (oat cell cancer).
  • Combined small cell carcinoma

After a diagnosis of small cell lung cancer, tests are performed to see if cancer cells have spread throughout the chest or to other areas of the body. Small cell lung cancer is diagnosed using some of the same techniques used to stage the illness. Staging is the procedure for determining whether cancer has migrated from the chest to other body regions. MRI of the brain, CT scan, PET scan, Bone scan.

Small cell lung cancer is classified into the following stages:

  • Limited-Stage Lung Cancer with Small Cells

Cancer in the limited stage has migrated to the space between the lungs or the lymph nodes above the collarbone from where it began in the lung.

  • Small Cell Lung Cancer in the Advanced Stage

Cancer has gone beyond the lung, the space between the lungs, or the lymph nodes above the collarbone to other parts of the body at the widespread stage.

  • After treatment, small cell lung cancer might recur (come back).

Cancer may return in the chest, central nervous system, or other body areas.

Non-Small Cell Lung Cancer

NSCLC (non–small cell lung cancer) accounts for over 85% of all lung cancers. NSCLC is classified histologically into adenocarcinoma, squamous cell carcinoma (SCC), and large cell carcinoma. Patients with NSCLC should get a comprehensive staging workup to determine the degree of their disease, as stage influences therapy options. Treatment options include surgery, chemotherapy, endoscopic stents, radiation therapy, targeted treatments, and immunotherapy.

Major differences between Small and Non-Small lung cancer:

  • Under a microscope, malignant cells in a person with small cell cancer seem small and spherical whereas, non-small cell lung cancer cells are bigger.
  • Small cell lung cancer is, on average, more aggressive than non-small cell lung cancer. Small cell lung cancer spreads more rapidly than non-small lung cancer.
  • Small cell lung cancer symptoms and non-small cell lung cancer symptoms are similar. The symptoms include a persistent cough, hoarse throat, shortness of breath and wheezing, chest pain and discomfort, loss of appetite, swelling in the veins of the face and neck, etc. Symptoms may not develop until cancer has progressed to a later stage.
  • Small cell lung cancer has 2 stages of diagnosis: the limited stage and the extensive stage. Non-small cell lung cancer has 4 stages of diagnosis: stages 1, 2, 3 and 4.
  • Treatments for small cell lung cancer mainly include chemotherapy, radiation therapy, surgery. Whereas treatment for non-small cell lung cancer includes surgery, chemotherapy, immunotherapy, targeted treatments, radiation therapy, and endoscopic stents.

Erlonat tablet 100mg is used to treat non-small cell lung cancer that has progressed to other body parts or is locally advanced. Erlonat tablet should be consumed one hour before or two hours after a meal. Diarrhea is a possible side effect.

Erlonat tablet (Erlotinib ), often known by the brand name Tarceva, is a type of targeted cancer medication. Erlonat tablet is used in conjunction with the chemotherapeutic drug gemcitabine to treat non-small cell lung cancer (NSCLC) that has spread (advanced) and advanced pancreatic cancer.

This article follows medical accuracy standards and current clinical guidelines.

Important Medical Disclaimer & Legal Notices

Medical Disclaimer: All content found on the Gandhi Medicos Website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.

Gandhi Medicos - Exporters of Generic Medicines. If you think you may have a medical emergency, call your doctor or go to the emergency department, or immediately. Gandhi Medicos does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on Gandhi Medicos. Reliance on any information provided by Gandhi Medicos, Gandhi Medicos employees, contracted writers, or medical professionals presenting content for publication to Gandhi Medicos is solely at your own risk.

The Site may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an “as is” basis. Gandhi Medicos - Exporters of Generic Medicines. Links to educational content not created by Gandhi Medicos are taken at your own risk. Gandhi Medicos is not responsible for the claims of external websites and education companies.

General Advisory: We advise you to stick to medication routine (or medication adherence), i.e. to take medications as prescribed – the right dose, at the right time, in the right way and frequency. Not taking medicines as prescribed by a doctor or instructed by a pharmacist could lead to disease getting worse, hospitalization, even death.

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk.

All Trademarks, Brands and Service marks that appear on this website belong to their respective owner.